alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Robert W. WING, Appellant, v. Monica D. WING, Appellee.

No. 1D17-0121

District Court of Appeal of Florida, First District.

February 21, 2018

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
Presidential Documents

16751 

Federal Register 

Vol. 74, No. 68 

Friday, April 10, 2009 

Title 3— 

The President 

Proclamation 8358 of April 8, 2009 

National D.A.R.E. Day, 2009 

By the President of the United States of America 

A Proclamation 

Drugs, gangs, and violence threaten our children and communities every 

day. Today we commemorate Drug Abuse Resistance Education (D.A.R.E.), 

a program that has worked to educate children and protect them from 

these problems. National D.A.R.E. Day provides the opportunity to reflect 

upon the dangers of drugs, gangs, and violence and to emphasize efforts 

to combat these threats. 

From inner cities to suburbs and rural communities, gangs and drug dealers 

prey upon youth across the United States. Unaware of the dangers of drug 

abuse and violence, many youth surrender the promise of a bright future. 

Every child lost in this battle represents a tragedy for our Nation, and 

we must do more to stop it. 

Education efforts to help children avoid drugs and violence must begin 

in the home. Parents must be positive role models and take the lead in 

advising their children on the effects of drugs on their health and wellbeing. 

The D.A.R.E. program has worked to educate students about drugs, gangs, 

and violence for more than 25 years. Placing law-enforcement personnel 

in the classroom, D.A.R.E. provides students with important lessons from 

experts and seeks to prepare them for the difficult encounters and choices 

they may face. 

Today we honor D.A.R.E. for its important work. The efforts of D.A.R.E.’s 

instructors and supporters benefit our Nation’s children and are deserving 

of praise and appreciation. D.A.R.E.’s renewed efforts to implement sciencebased programs and to strengthen partnerships among law enforcement, 

families, and their communities are particularly worthy of commendation. 

Through effective teaching methods and broad participation, D.A.R.E. can 

help ensure that every child in America enjoys the opportunities he or 

she deserves. 

NOW, THEREFORE, I, BARACK OBAMA, President of the United States 

of America, by virtue of the authority vested in me by the Constitution 

and laws of the United States, do hereby proclaim April 8, 2009, as National 

D.A.R.E. Day. I call upon our youth, parents, educators, law enforcement 

personnel, and all the people of the United States to observe this day 

with appropriate programs and activities. 

16752 Federal Register / Vol. 74, No. 68 / Friday, April 10, 2009 / Presidential Documents 

IN WITNESS WHEREOF, I have hereunto set my hand this eighth day 

of April, in the year of our Lord two thousand nine, and of the Independence 

of the United States of America the two hundred and thirty-third. 

[FR Doc. E9–8446 

Filed 4–9–09; 11:15 am] 

Billing code 3195–W9–P 


OB#1.EPS</GPH>
DISTRICT COURT OF APPEAL OF THE STATE OF FLORIDA

FOURTH DISTRICT

JOSEPH SCHEIGERT,

Appellant,

v.

STATE OF FLORIDA,

Appellee.

No. 4D19-2821

[October 29, 2020]

Appeal from the Circuit Court for the Seventeenth Judicial Circuit, 

Broward County; Barbara Anne McCarthy, Judge; L.T. Case No. 15-6029-

CF-10A.

Carey Haughwout, Public Defender, and Alan T. Lipson, Assistant 

Public Defender, West Palm Beach, for appellant.

Ashley Moody, Attorney General, Tallahassee, and Anesha Worthy, 

Assistant Attorney General, West Palm Beach, for appellee.

PER CURIAM.

Affirmed.

GERBER, CONNER and KLINGENSMITH, JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.
Exhibit 99.4 - Administrative Report of the Trust

                              Administrative Report
                                       for

            Hartford Life Global Funding Trust 2004-002 (the "Trust")

                           Payment Date March 15, 2005
                           CUSIP Number 41659FAB0

(i) the amount received by the Indenture Trustee from Hartford Life Insurance
Company ("Hartford Life") as of the payment date in respect of the principal,
interest and premium, if any, on Funding Agreement No. 404002 (the "Funding
Agreement") issued by Hartford Life Insurance Company ("Hartford Life").

                       -----------------------------------
                       Interest:       $ 26,101.00
                       -----------------------------------
                       Principal:      $ 0.00
                       -----------------------------------

(ii)  the amount of payment on such Payment Date to holders allocable to
      principal and interest on the notes of the Trust.

                       -----------------------------------
                       Interest:       $ 26,101.00
                       -----------------------------------
                       Principal:      $ 0.00
                       -----------------------------------

(iii) the aggregate stated principal amount of the Funding Agreement, the
      current interest rate or rates thereon at the close of business on such
      Payment Date, and the current rating assigned to the Funding Agreement.

          --------------------------------------------------------
          Aggregate Principal Amount:       $ 1,214,015.00
          --------------------------------------------------------
          Interest Rate:                    4.50%
          --------------------------------------------------------

                               Ratings:

                                       Moody's Investor Services: Aa3
                                       Standard & Poors' Rating Service: AA-

(iv)the aggregate principal balance of the notes of the Trust at the close of
    business on such Payment Date and the current rating assigned to such notes.

                               Aggregate Principal Amount: $ 1,214,000.00

                               Ratings:

                                       Moody's Investor Services: Aa3
                                       Standard & Poors' Rating Service: AA-

AMACAR Pacific Corp., as administrator of Hartford Life Global Funding Trust
2004-002


By: /s/ Evelyn Echevarria
    ----------------------------
    Name: Evelyn Echevarria
    Title: Vice President
DO SAOPAULO, INC., Appellant, v. WELLS FARGO BANK NATIONAL ASSOCIATION, as Trustee FOR BANC OF AMERICA ALTERNATIVE LOAN TRUST 2006-7 MORTGAGE PASS-THROUGH CERTIFICATES, SERIES 2006-7, et al., Appellees.

Case No. 5D17-3472

District Court of Appeal of Florida, Fifth District.

Decision filed February 6, 2018

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2460 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2460

         To suspend temporarily the duty on gallium unwrought.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             April 26, 2012

  Mr. Schumer introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
         To suspend temporarily the duty on gallium unwrought.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. GALLIUM UNWROUGHT.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00        Gallium unwrought   Free            No change      No change      On or before     ''.
                          (CAS No. 7440-55-                                                 12/31/2015
                          3 or 231-163-8)
                          (provided for in
                          subheading
                          8112.92.10)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
Exhibit 31.2

CERTIFICATION BY PRINCIPAL FINANCIAL OFFICER
PURSUANT TO RULE 13a-14

I, Jon Correio, certify that:

1.

I have reviewed this Form 10-Q for the quarter ended September 30, 2008 of Electronic Systems Technology Inc.;

2.

Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3.

Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4.

The small business issuer's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and have:
a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
b)[Omitted as permitted by Exchange Act Release No. 47986];
c)Evaluated the effectiveness of the small business issuers disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the small business issuers internal control over financial reporting that occurred during the small business issuers most recent fiscal quarter (the small business issuers fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the small business issuers internal control over financial reporting; and

5.

I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the small business issuers auditors and the audit committee of the small business issuers board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuers ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuers internal control over financial reporting.

Date:  November 11, 2008

By: /s/ JON CORREIO
Jon Correio
Vice President, Finance and Administration
Exhibit 32

CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C.
SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

I, Daniel C. Montano, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that
the Annual Report of CardioVascular BioTherapeutics, Inc. (the Company) on Form 10-K/A for the fiscal year ended December 31, 2006 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of
1934 and that information contained in such Annual Report on Form 10-K/A fairly presents in all material respects the financial condition and results of operations of the Company.



|                   |  |              |  |                                                           
|------------------ |  | ------------ |  | ----------------------------------------------------------
|Date: May 21, 2007 |  | By:          |  | /s/    DANIEL C.
MONTANO                                  
|                   |  | Name: Title: |  | Daniel C. Montano Co-President and Chief Executive Officer

I, Mickael A. Flaa, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of CardioVascular BioTherapeutics, Inc. (the Company) on Form 10-K/A for the fiscal year ended December 31, 2006 fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Annual Report on Form 10-K/A fairly presents in all material respects the financial condition and results of operations of the Company.



|                   |  |              |  |                                        
|------------------ |  | ------------ |  | ---------------------------------------
|Date: May 21, 2007 |  | By:          |  | /s/    MICKAEL A.
FLAA                 
|                   |  | Name: Title: |  | Mickael A. Flaa Chief Financial Officer

Signed originals of these written statements required by Section 906 of the
Sarbanes-Oxley Act of 2002 have been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

These certifications accompany the Form 10-K/A to which they relate, are not deemed filed with the Securities and Exchange Commission and are not to
be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Securities Exchange Act of 1934 (whether made before or after the date of this Form 10-K/A, irrespective of any general incorporation language
contained in such filing.
Curtis FEIMSTER, Appellant, v. The STATE of Florida, Appellee.

No. 3D18-168

District Court of Appeal of Florida, Third District.

Opinion filed March 7, 2018

Curtis Feimster, in proper person.

Pamela Jo Bondi, Attorney General, for appellee.

Before EMAS, FERNANDEZ and LUCK, JJ.

PER CURIAM.

Affirmed. *See* § 782.04(2), Fla. Stat. (1982) (providing that second-degree murder is a first-degree felony punishable by a term of years not exceeding life imprisonment).
Harry Brant LANCASTER, Jr. v. Kylia Haskew ROSS

2150680

Court of Civil Appeals of Alabama.

January 6, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Donald Godfrey ROBINSON, Jr., Appellant, v. STATE of Florida, Appellee.

No. 4D16-1304

District Court of Appeal of Florida, Fourth District.

[March 1, 2018]

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Jessica SMITH, Appellant, v. Drew BRECHEEN, Appellee.

Case No. 5D17-1042

District Court of Appeal of Florida, Fifth District.

Decision filed December 19, 2017

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
II 

112TH CONGRESS 

2D SESSION S. 2504 

To suspend temporarily the duty on D-Galacto-D-mannan, 2-hydroxy-3- 

(trimethylammonio)propyl ether, chloride (83589–59–7), 1- 

Propanaminium, 2,3-dihydroxy-N,N,N-trimethyl-, chloride (34004–36–9) 

and water. 

IN THE SENATE OF THE UNITED STATES 

APRIL 26, 2012 

Mr. BROWN of Ohio introduced the following bill; which was read twice and 

referred to the Committee on Finance 

A BILL 

To suspend temporarily the duty on D-Galacto-D-mannan, 

2-hydroxy-3-(trimethylammonio)propyl ether, chloride 

(83589–59–7), 1-Propanaminium, 2,3-dihydroxy-N,N,Ntrimethyl-, chloride (34004–36–9) and water. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


tjames on DSK6SPTVN1PROD with BILLS
2 

•S 2504 IS

1 SECTION 1. D-GALACTO-D-MANNAN, 2-HYDROXY-3- 

2 (TRIMETHYLAMMONIO)PROPYL ETHER, 

3 CHLORIDE (83589–59–7), 1-PROPANAMINIUM, 

4 2,3-DIHYDROXY-N,N,N-TRIMETHYL-, CHLO5 RIDE (34004–36–9) AND WATER. 

6 (a) IN GENERAL.—Subchapter II of chapter 99 of 

7 the Harmonized Tariff Schedule of the United States is 

8 amended by inserting in numerical sequence the following 

9 new heading: 

‘‘ 9902.01.00 D-Galacto-D-mannan, 

2-hydroxy-3- 

(trimethylammonio)propyl 

ether, chloride (83589–59–7), 

1-Propanaminium, 2,3- 

dihydroxy-N,N,N-trimethyl-, 

chloride (34004–36–9) and 

water (CAS Nos. 83589–59– 

7, 34004–36–9) (provided for 

in subheading 1302.39.00) ... Free No change No change On or before 

12/31/2015 ’’. 

10 (b) EFFECTIVE DATE.—The amendment made by 

11 subsection (a) applies with respect to goods entered, or 

12 withdrawn from warehouse for consumption, on or after 

13 the 15th day after the date of the enactment of this Act. 

Æ 


tjames on DSK6SPTVN1PROD with BILLS
Electronically Filed Supreme Court SCWC-12-0000589 11-JUL-2014 09:38 AM

SCWC-12-0000589 IN THE SUPREME COURT OF THE STATE OF HAWAI ' I
STATE OF HAWAI ' I, Respondent/Plaintiff-Appellant,
vs. RICHARD K. MYERS, Petitioner/Defendant-Appellee.
CERTIORARI TO THE INTERMEDIATE COURT OF APPEALS (CAAP-12-0000589; CASE NO. 11-1-1681) ORDER REJECTING APPLICATION FOR WRIT OF CERTIORARI ( By: Recktenwald, C.J., Nakayama, McKenna, Pollack, and Wilson, JJ.) Petitioner/Defendant-Appellee’s Application for Writ of Certiorari, filed on May 28, 2014, is hereby rejected. DATED: Honolulu, Hawai ' i, July 11, 2014. James S. Tabe for petitioner /s/ Mark E. Recktenwald /s/ Paula A. Nakayama Sonja P. McCullen for respondent /s/ Sabrina S. McKenna /s/ Richard W. Pollack /s/ Michael D. Wilson
Peter STANWAY, Appellant, v. STATE of Florida, Appellee.

No. 4D16-1725

District Court of Appeal of Florida, Fourth District.

[January 4, 2018]

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
# Official Journal C 25/1 Fe

| | ISSN 1725-2423 |
| --- | --- |
| Official Journal
  of the European Union | C 25 |
| | |
| English edition | Information and Notices | Volume 481 February 2005 |

ISSN 1725-2423

Official Journal

of the European Union

C 25

English edition

Information and Notices

Volume 481 February 2005

---

| Notice No | Contents | page |
| --- | --- | --- |
| | I   Information |
| | Commission |
| 2005/C 025/1 | Euro exchange rates | 1 |
| 2005/C 025/2 | Notice to importers — WTO Dispute Settlement proceeding concerning the US tax treatment of Foreign Sales Corporations (‘FSC’) — Repayment or Remission of Additional Duties | 2 |

Notice No

Contents

page

I   Information

Commission

2005/C 025/1

Euro exchange rates

1

2005/C 025/2

Notice to importers — WTO Dispute Settlement proceeding concerning the US tax treatment of Foreign Sales Corporations (‘FSC’) — Repayment or Remission of Additional Duties

2

---

| | III   Notices |
| --- | --- |
| | Council |
| 2005/C 025/3 | Extension of the period of validity of the shortlists of suitable candidates drawn up following open competitions Council/LA/364, Council/LA/365, Council/LA/381, Council/LA/384, Council/LA/385, Council/LA/386, Council/LA/398, Council/LA/399, Council/C/389 and EUR/C/120 | 3 |

III   Notices

Council

2005/C 025/3

Extension of the period of validity of the shortlists of suitable candidates drawn up following open competitions Council/LA/364, Council/LA/365, Council/LA/381, Council/LA/384, Council/LA/385, Council/LA/386, Council/LA/398, Council/LA/399, Council/C/389 and EUR/C/120

3

---

| EN | |
| --- | --- |

EN
# Official Journal C 201/30 J

| | ISSN 1977-091X |
| --- | --- |
| Official Journal
  of the European Union | C 201 |
| | |
| English edition | Information and Notices | Volume 5730 June 2014 |

ISSN 1977-091X

Official Journal

of the European Union

C 201

English edition

Information and Notices

Volume 5730 June 2014

---

| Notice No | Contents | page |
| --- | --- | --- |
| | IV   Notices |
| | NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Parliament |
| 2014/C 201/1 | Report on budgetary and financial management — Section I: European Parliament — Financial year 2013 | 1 |

Notice No

Contents

page

IV   Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Parliament

2014/C 201/1

Report on budgetary and financial management — Section I: European Parliament — Financial year 2013

1

---

| EN | |
| --- | --- |

EN
CERTIFICATIONS

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER

I, Thomas R. Dickinson, certify that:

1.   I have reviewed this quarterly report on Form 10-Q of
  Miltope Group, Inc. (the "registrant");
2.   Based on my knowledge, this quarterly report does not
contain any untrue statement of a material fact or omit to state
a material fact necessary to make the statements made, in light
of the circumstances under which such statements were made, not
misleading with respect to the period covered by this quarterly
report;
3.   Based on my knowledge, the financial statements and other
financial information included in the quarterly report, fairly
present in all material respects the financial condition, results
of operations and cash flows of the registrant as of, and for the
periods presented in this quarterly report;
4.   The registrant's other certifying officers and I are
responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules 13a-14 and 15d-
14) for the registrant and we have:
  a)   Designed such disclosure controls and procedures to ensure
     that material information relating to the registrant, including
     its consolidated subsidiaries, is made known to us by others
     within those entities, particularly during the period in which
     this quarterly report is being prepared;
b)   Evaluated the effectiveness of the registrant's disclosure
controls and procedures as of the date within 90 days prior to
the filing date of this quarterly report (the "Evaluation Date");
and
c)   Presented in the quarterly report our conclusions about the
effectiveness of the disclosure controls and procedures based on
our evaluation as of the Evaluation Date;
5.   The registrant's other certifying officers and I have
  disclosed, based on our most recent evaluation, to the
  registrant's auditors and the audit committee of the registrant's
  board of directors (or persons performing the equivalent
  function):
  a)   All significant deficiencies in the design or operation of
     internal controls which could adversely affect the registrant's
     ability to record, process, summarize and report financial data
     and have identified for the registrant's auditors any material
     weaknesses in internal controls; and
b)   Any fraud, whether or not material, that involves management
or other employees who have a significant role in the
registrant's internal controls; and
  6.   The registrant's other certifying officers and I have
     indicated in the quarterly report whether or not there were
     significant changes in internal controls or in other factors that
     could significantly affect internal controls subsequent to the
     date of our most recent evaluation, including any corrective
     actions with regard to significant deficiencies and material
     weaknesses.

Date:  May 14, 2003                     /s/ Thomas R. Dickinson
                                    	---------------------------------
					President and Chief
  					Executive Officer